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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S368Conclusions: We demonstrated in the present study that the lower
serum levels of PIICP, that indicate the reduction of cartilage synthesis,
were associated with the lower JSW, that is an one of the typical signs of
OA. We speculate that the joint space narrowing could occur when the
cartilage repair system is burned out according to the lower cartilage
synthesis potential. In conclusion, the lower cartilage synthesis was
associated with the radiographic joint space narrowing of the knee joint
in men in early forties.
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MANGIFERIN STIMULATES CHONDROGENIC DIFFERENTIATION OF
MESENCHYMAL STEM CELLS FROM SUBCHONDRAL BONE AND
TARGETS MULTIPLE ASPECTS OF SMADS AND SOX9 PATHWAYS
J. Huh, P. Koh, B-K. Seo, Y-H. Baek, D-Y. Choi, J-D. Lee, D-S. Park. Kyung
Hee Univ., Seoul, REPUBLIC OF KOREA
Purpose: To assess the effect that mangiferin(1), a standard component
of WIN-34B, has on chondrogenic differentiation of mesenchymal stem
cells(MSCs) from rabbit subchondral bone.
Methods: Histological analysis was performed by alcian blue, oil red O,
and alizarin red staining to evaluate if progenitor cells from rabbit
subchondral bone have chondrogenic, adipogenic, and osteogenic dif-
ferentiation capacity. Changes in levels of chondrogenic markers type II
a1 collagen(col2a1), cartilage protein, SOX9, and aggrecan after man-
giferin treatment in IL-1b-stimulated MSCs were observed. Sulfated
glycosaminoglycan(sGAG), type II collagen, chondrogenic markers
col2a1, cartilage link protein, SOX9, aggrecan, proinﬂammatory cyto-
kines, matrix metallo proteinases(MMPs), and growth factors bone
morphogenic protein-2(BMP-2), BMP-4, basic ﬁbroblast growth fac-
tor(bFGF), and transforming growth factor-b(TGF-b) which are related
to chondrogenesis were also observed for changes in the same setting.
The mRNA expression was assessed by real time polymerase chain
reaction(RT-PCR), and protein levels were determined by ELISA assay.
Changes in chondrogenesis-related pathways Smad and SOX9 were
observed by Western blotting.
Results: sGAG and type II collagen increased after IL-1b-stimulated
MSCs, and decreased after mangiferin administration. Chondrogenic
markers col2a1, cartilage link protein, SOX9, and aggrecan were
decreased in IL-1b-stimulated MSCs, but increased after mangiferin
treatment. Proinﬂammatory cytokines(IL-1b, TNF-a) and MMP-1, MMP-
3 which increased after IL-1b stimulation of MSCs decreased after
mangiferin treatment. Chondrogenesis-related growth factors BMP-2,
BMP-4, bFGF, TGF-b were decreased in IL-1b-stimulated MSCs, but
increased after mangiferin treatment. Western blotting of IL-1b-
stimulated MSCs revealed that IL-1b disrupted chondrogenic differ-
entiation by down-regulation of phosphorylation of Smad2, 3, 1/5/8 and
SOX 9, and mangiferin up-regulated phosphorylation of Smad2,3 1/5/8
and SOX 9 and thus restored chondrogenic differentiation.
Conclusions: Mangiferin has chondroprotective and chondrogenic
differentiation promoting effects on MSCs from subchondral bone, and
does so by acting on the Smad and SOX9 pathways.
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IDENTIFYING STRUCTURAL CUES INVOLVED WITH OSTEOARTHRITIS
DISEASE IN HUMAN HUMERAL HEADS
D.J. Pawson y, M. Glanzmann z, H. Bangar y, K. Atal y, R. M€uller y,
K.S. Stok y. y ETH Zurich, Zurich, Switzerland; z Schulthess Clinic, Zurich,
Switzerland
Purpose: The concomitant structural changes to bone and cartilage in
osteoarthritis (OA) are poorly understood. It is known that both tissues
are affected, speciﬁcally degradation of cartilage alongside change to
subchondral trabecular bone structure. However, a one-to-one assess-
ment of the two tissues in relation to each other is not available. This
insight would allow categorization of disease state, as well as targeted
drug treatment for structure-modifying effects or plans of care for
physical therapy. The aim of this study is evaluate humeral heads from
end stage OA patients to correlate spatially relevant structural change
between the cartilage and bone tissues.
Methods: Humeral head samples were harvested from 9 female
patients undergoing joint replacement for end stage OA. Consent from
the patients and approval of the local ethics committee was received.
Average patient age at resection was 72 þ/- 15 years, and body mass
index of 27 þ/- 5 kg/m2. Patient history was recorded includingsecondary conditions (e.g. osteoporosis or rheumatoid arthritis) and
ongoing osteoporosis or glucocorticoid treatment, i.e. treatments with
potential structural effects.
Following surgery, the samples were scanned using micro-computed
tomography, microCT (mCT 80, Scanco Medical, Br€uttisellen, CH) at an
isotropic voxel size of 30 mm, followed by magnetic resonance imaging,
MRI (Achieva, 3.0 Tesla, Philipps, Andover, MA, USA). The samples were
immersed in Fombolin oil to enhance cartilage contrast, and scanned at
150 mm in-plane (300 mm out-of-plane) resolution using a T1 enhanced
Gradient Echo Sequence, with water selective excitation. The cartilage
was extracted from the MRI images, and then registered with the
microCT scan for further processing. Five anatomical regions of interest
were deﬁned for each sample (i.e. anterior, lateral, medial, posterior and
a central core).
Quantitative bone and cartilage morphometric analysis was then per-
formed for standard measures such as bone volume density (BV/TV),
trabecular thickness (Tb.Th), trabecular spacing (Tb.Sp), and cartilage
thickness (Cg.Th). Also the denuded surface was calculated as the per-
centage of bone surface not covered by cartilage, (%DS). Morphometric
parameters of interest were then plotted. Gross visual examination of
the data was compared with morphometry and patient history to
identify patterns of interest that could explain correlated data.
Results: Gross visual examination indicated that the samples fell into
two groups - effectively those with an osteoporosis-like structure (n ¼
2), often displaying large regions of very low to no trabeculae, ﬁgure 1a,
and those with overt sclerosis of the subchondral bone (n ¼ 6), often in
the presence of large holes (visualised as bone marrow oedema on the
MRI scans) and osteophytes, ﬁgure 1b. One sample ﬁt into neither
categorization, appearing structurally “healthy”. This sample was
omitted from the subsequent analysis. No correlation was observed
between the categorisation of a sample and the patient history.
Figure 1. (a) Osteoporosis-like sample with intact cartilage and complete
loss of trabecular structure (indicated by arrow), (b) Sclerotic sample with
loss of cartilage covering the bone, osteophyte growth (right arrow), and
large bone marrow oedema holes (left arrows). Colour indicates cartilage
thickness, where blue is thinnest and red is thickest.
Morphometric analysis indicated that the two samples with an osteo-
porosis-like structure showed no relation to cartilage measures (%DS or
Cg.Th). However for samples with sclerotic bone change, there were
signiﬁcant correlations between the bone and cartilagemorphometry, p
< 0.01. Speciﬁcally, in regions of thin cartilage the trabecular thickness
was thicker and vice versa (see ﬁgure 2a), and for regions with a large %
DS, the BV/TV was also greater (see ﬁgure 2b). Additionally, the dense
bone and loss of cartilage appeared to predominantly affect the anterior
region of the humeral heads.
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each sample speciﬁc correlation yields an inverse relationship in sclerotic
samples. Individual correlation coefﬁcients are R ¼ 0.62, 0.87, 0.88, 0.85.
0.60, 0.77, respectively, (b) Plot of denuded surface and bone volume/total
volume, indicating, for each sample, greater bone density in regions of lost
cartilage coverage. Individual correlation coefﬁcients are R ¼ 0.41, 0.84,
0.74, 0.38, 0.80, 0.41, respectively. The combined correlation coefﬁcients
for Cg.Th versus Tb.Th and %DS versus BV/TV, are 0.74 and 0.56, respec-
tively.
Conclusions: The results of this work show different relationships
between cartilage and bone structures in end stage OA samples dis-
playing bone sclerosis, than for samples with a more osteoporosis-like
change. This suggests that identifying the structural cues involved with
OA disease progression could allow for a more accurate diagnosis of
disease. It must be stated, however, that more osteoporotic-like samples
will need to be measured to conﬁrm this result. Speciﬁcally, changes
associated with sclerotic or osteoporotic-like bone change may require
alternative physical therapy or drug regimes. Future work will focus on
correlating these structural changes to speciﬁc genes and signalling
pathways, as well as biomechanical loading and use patterns in the
shoulder joint.
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NKX3.2-BARX1 CROSSTALK IN CHONDROCYTE AND ITS ROLE IN
OSTEOARTHRITIS PATHOGENESIS
D-W. Kim. Yonsei Univ., Seoul, REPUBLIC OF KOREA
Osteoarthritis (OA) is a prevalent disease affecting majority of aged
human, yet its effective treatment is currently absent. We have pre-
viously shown that Nkx3.2-mediated consitutive activation of NF-kB
functions to maintain chondrocyte viability. Besides, Barx1 has been
implicated for its role in development of gut, spleen and craniofacial
skeletons, but its precise molecular function in chondrocyte has been
poorly understood. Here we show that Barx1 can induce programmed
cell death in chondrocyte by abrogating Nkx3.2-mediated NF-kB acti-
vation. Interestingly, we also observed remarkable decrease and
increase in Nkx3.2 and Barx1 expression, respectively, both in mouse
OA models and in human OA patients. Consistent with these, in vivo
experiments employing intra-articular infection of Lentivirusmodifying Nkx3.2 or Barx1 expression revealed that osteoarthritic
cartilage destruction can be suppressed by Nkx3.2, whereas Barx1
aggravates it. Furthermore, importantly, we observed that either Nkx3.2
overexpression or Barx1 knockdown is capable of rendering regener-
ation of damaged cartilage in DMM-OA analyses in mice. Lastly, we
demonstrate that OA progression is decelerated and accelerated in
Nkx3.2 transgenic and knockout mice, respectively. Thus, these results
indicate that Nkx3.2-Barx1 crosstalk plays a role in OA pathogenesis
and may serve as promising therapeutic targets for OA modiﬁcation.
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INVESTIGATION ON THE ROLE OF DELTA/NOTCH LIKE EGF-RELATED
RECEPTOR IN THE PATHOGENESIS OF OSTEOARTHRITIS
L. Berninger y, A. Balkenhol y, C. Baier z, U. M€uller-Ladner y,
E. Neumann y, M. Geyer y. y Justus-Liebig-Univ. of Giessen, Kerckhoff-
Klinik, Bad Nauheim, Germany; zUniv. of Regensburg, Regensburg,
Germany
Purpose: Delta/Notch like EGF-related receptor (DNER) is a single-pass
transmembrane protein with characteristic EGF-like repeats in the
extracellular domain, similar to those of the Notch receptor and its
ligand Delta. In our previous study, an overexpression of DNER mRNA
was observed in lesional areas of human osteoarthritis (OA) articular
cartilage compared to unaffected zones of the same tissue sample.
Based on these ﬁndings and on the fact that the Notch signaling path-
way plays a major role in cell fate regulation and differentiation of
human articular chondrocytes, we analyzed the role of DNER in the
pathogenesis of OA.
Methods: Articular cartilagewas obtained fromOA patients undergoing
joint replacement surgery. The expression of DNER in human cartilage
was analyzed by immunohistochemistry. Normal human articular
chondrocytes (HNAC-kn) purchased from Lonza, Walkersville, MD, USA
were nucleofected with an overexpression vector targeting DNER and a
vector control. Overexpression of DNER was conﬁrmed by immunocy-
tochemical staining. For determining the effect of DNER overexpression
on speciﬁc cartilage metabolic parameters gene chip technology
(Affymetrix) and semi-quantitative real-time PCR was used.
Results: Histologically, DNER was signiﬁcantly increased in the affected
cartilage of all patients (n¼ 3) compared to the intact zones of the same
tissue. After nucleofection an upregulation of DNER in normal human
chondrocytes was detectable on protein level. Gene chip technology
showed that DNER overexpression caused an upregulation of the Spen
family transcriptional repressor (1.86 fold) and a downregulation of
Bone marrow stromal cell antigen 2 (-2.2 fold) and Tripartite motif
containing 22 (-2.07 fold). No changes were detectable on speciﬁc car-
tilage metabolic parameters like Collagen type 2, Sox9, MMP13,
ADAMTS4 and ADAMTS5, as well as on differentiation markers like
Collagen type 1 and a target gene of the Notch signaling pathway, HES-1.
Conclusion: Reorganization and reassembly of cartilage extracellular
matrix through downstream effects of DNER overexpression might be
enhanced by chondrocyte hypertrophy via upregulation of Spen family
transcriptional repressor, whilst downregulation of the integrin-
induced proteins Bone marrow stromal cell antigen 2 and Tripartite
motif containing 22 may inﬂuence programmed apoptosis and pro-
liferation, eventually via intermediate inﬂammatory stages.
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BONE CHANGES PRECEED CARTILAGE DEGRADATION IN
EXPERIMENTAL OSTEOARTHRITIS
C. Huesa y, L. McGavin y, A. Habgood z, J.C. Lockhart y, R. van ’t Hof x,
A.D. Rowan z, C. Goodyear k, I. MacInnes k, W.R. Ferrell k. yUniv. of the
West of Scotland, Glasgow, United Kingdom; zUniv. of Newcastle,
Newcastle, United Kingdom; xUniv. of Liverpool, Liverpool, United
Kingdom; kUniv. of Glasgow, Glasgow, United Kingdom
Purpose: Osteoarthritis (OA) is characterized by cartilage degradation
and osteophyte formation. Although cartilage degradation has been the
primary target for research on the pathogenesis of OA, there is
increasing recognition of the importance of bone changes in driving the
disease process. This study characterises the temporal proﬁle of bone
and cartilage changes in murine OA, speciﬁcally focusing on osteophyte
development and subchondral bone changes.
Methods: OA was induced in C57Bl/6 mice by destabilisation of the
medical meniscus (DMM), or sham operated, and bone was assessed by
